BTAX (Biostax) E10: $0.00 (As of Sep. 2024)


What is Biostax E10?

Biostax BTAX E10 is $0.00 as of Sep. 2024.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biostax's adjusted earnings per share data for the three months ended in Sep. 2024 was $0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), Biostax's current stock price is $0.0001. Biostax's E10 for the quarter that ended in Sep. 2024 was $0.00. Biostax's Shiller PE Ratio of today is .


Biostax  (OTCPK:BTAX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biostax E10 Related Terms


Biostax E10 Historical Data

* Premium members only.

The historical data trend for Biostax's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biostax E10 Chart

Biostax Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -727.01 -331.92 -99.69

Biostax Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -99.69 -71.68 -61.29 0.00

BTAX vs TRVN, HSTC, SYRS: E10 Comparison

For the Biotechnology subindustry, Biostax's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostax Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biostax's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biostax's Shiller PE Ratio falls into.



Biostax E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biostax's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0/315.3010*315.3010
=0.000

Current CPI (Sep. 2024) = 315.3010.

Biostax Quarterly Data

per share eps CPI Adj_EPS
201412 -95.218 234.812 -127.857
201503 -20.000 236.119 -26.707
201506 -20.000 238.638 -26.425
201509 -20.000 237.945 -26.502
201512 -30.000 236.525 -39.992
201603 -30.000 238.132 -39.722
201606 -20.000 241.018 -26.164
201609 -20.000 241.428 -26.120
201612 -20.000 241.432 -26.119
201703 -10.000 243.801 -12.933
201706 0.893 244.955 1.149
201709 -4.052 246.819 -5.176
201712 -10.000 246.524 -12.790
201803 -1.575 249.554 -1.990
201806 -10.000 251.989 -12.512
201809 -6.390 252.439 -7.981
201812 -2.173 251.233 -2.727
201903 -1.580 254.202 -1.960
201906 -1.810 256.143 -2.228
201909 -2.070 256.759 -2.542
201912 -2.120 256.974 -2.601
202003 -1.730 258.115 -2.113
202006 -1.760 257.797 -2.153
202009 0.240 260.280 0.291
202012 -2.020 260.474 -2.445
202103 0.050 264.877 0.060
202106 -0.230 271.696 -0.267
202109 0.240 274.310 0.276
202112 -0.430 278.802 -0.486
202203 -5.290 287.504 -5.801
202206 0.230 296.311 0.245
202209 -0.040 296.808 -0.042
202212 -0.003 296.797 -0.003
202303 -0.005 301.836 -0.005
202306 -0.010 305.109 -0.010
202309 0.000 307.789 0.000
202312 -0.010 306.746 -0.010
202403 -0.004 312.332 -0.004
202406 -0.010 314.175 -0.010
202409 0.000 315.301 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.00 mean?
Biostax (BTAX) has a E10 of $0.00 as of Sep. 2024. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biostax and its competitors.
Is Biostax's E10 too high?
Biostax's current E10 is $0.00.
How does Biostax's E10 compare to TRVN and HSTC?
Biostax's E10 of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biostax and its competitors. Biostax's current E10 is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biostax stock overvalued right now?
Biostax (BTAX) has a current E10 of $0.00. The current E10 is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Biostax (BTAX), the current E10 is $0.00 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biostax Business Description

Address 2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.